Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations(25 sites)
United States
Tuscaloosa VA Medical Center, Tuscaloosa, AL, Tuscaloosa, Alabama Phoenix VA Health Care System, Phoenix, AZ, Phoenix, Arizona VA Long Beach Healthcare System, Long Beach, CA, Long Beach, California VA Palo Alto Health Care System, Palo Alto, CA, Palo Alto, California San Francisco VA Medical Center, San Francisco, CA, San Francisco, California CERC (VISN1, West Haven, CT), West Haven, Connecticut VA Connecticut Healthcare System West Haven Campus, West Haven, CT, West Haven, Connecticut Wilmington VA Medical Center, Wilmington, DE, Wilmington, Delaware Bay Pines VA Healthcare System, Pay Pines, FL, Bay Pines, Florida North Florida/South Georgia Veterans Health System, Gainesville, FL, Gainesville, Florida VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston, Massachusetts Minneapolis VA Health Care System, Minneapolis, MN, Minneapolis, Minnesota Louis Stokes VA Medical Center, Cleveland, OH, Cleveland, Ohio Dayton VA Medical Center, Dayton, OH, Dayton, Ohio Philadelphia MultiService Center, Philadelphia, PA, Philadelphia, Pennsylvania VA Pittsburgh Healthcare System University Drive Division, Pittsburgh, PA, Pittsburgh, Pennsylvania Providence VA Medical Center, Providence, RI, Providence, Rhode Island VA North Texas Health Care System Dallas VA Medical Center, Dallas, TX, Dallas, Texas VA Salt Lake City Health Care System, Salt Lake City, UT, Salt Lake City, Utah White River Junction VA Medical Center, White River Junction, VT, White River Junction, Vermont Hampton VA Medical Center, Hampton, VA, Hampton, Virginia Salem VA Medical Center, Salem, VA, Salem, Virginia VA Puget Sound Health Care System Seattle Division, Seattle, WA, Seattle, Washington Huntington VA Medical Center, Huntington, WV, Huntington, West Virginia Clement J. Zablocki VA Medical Center, Milwaukee, WI, Milwaukee, Wisconsin